Vitamin E-tocopheryl polyethylene glycol succinate decorated drug delivery system with synergistic antitumor effects to reverse drug resistance and immunosuppression

被引:9
|
作者
Guan, Ying-Ying [1 ]
Zeng, Shao-Qi [1 ]
Qin, Yin [1 ]
Mu, Yan [1 ]
Liu, Hong [1 ]
机构
[1] Hubei Univ, Natl & Local Joint Engn Res Ctr High Throughput D, Key Lab Biotechnol Chinese Tradit Med Hubei Prov, Coll Life Sci,Hubei Collaborat Innovat Ctr Green, Wuhan 430062, Peoples R China
关键词
Drug delivery; Nanoparticles; Curcumin; TPGS; Drug resistance; OVERCOMING MULTIDRUG-RESISTANCE; E TPGS; CANCER; NANOPARTICLES; ANTICANCER; CURCUMIN; INHIBITION; APOPTOSIS; METASTASIS; MICELLES;
D O I
10.1016/j.colsurfa.2021.127387
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
To overcome cancer drug resistance and to reverse tumor immunosuppression, a vitamin E-tocopheryl polyethylene glycol succinate (TPGS) decorated polymer-based drug delivery system was developed. The effects of the drug delivery system on diverse proteins involved in cell apoptosis, cancer invasion, metastasis and immunosuppression were investigated to provides a more comprehensive understanding of TPGS modified drug delivery systems. Curcumin (CUR), a hydrophobic drug, was loaded in star poly(DL-lactide) with a cholic acid core, and then decorated with TPGS shell to obtain CUR@TPGS/star poly(DL-lactide) nanoparticles (CUR@TPNP). Cholic acid cored star poly(DL-lactide) is featured by a rapid degradation rate with a surface erosion characteristic. TPGS not only reverses tumor drug resistance through downregulating P-gp expression of tumor cells but also enhances the anti-tumor efficiency through combined TPGS/CUR therapeutic actions on reversal of tumor immunosuppression mediated by CD47 and PD-L1. As compared with the CUR loaded nanoparticles without TPGS decoration, CUR@TPNP with TPGS decoration results in significantly enhanced intracellular drug accumulation to efficiently induce cell apoptosis in drug resistant tumor cells. More importantly, CUR@TPNP possesses considerably improved efficacy in upregulating p53 and p21 as well as downregulating beta-catenin, MMP-9, Snail, CD47 and PD-L1, indicating the TPGS decorated drug delivery system inhibits tumor development and metastasis much more efficiently.
引用
收藏
页数:7
相关论文
共 32 条
  • [1] On the combined use of cyclodextrins and D-α-tocopheryl polyethylene glycol succinate as a drug delivery system
    Gonzalez-Gaitano, Gustavo
    Dreiss, Cecile
    Puig, Joan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [2] Development of a novel drug delivery system consisting of an antitumor agent tocopheryl succinate
    Hama, Susumu
    Utsumi, Satoru
    Fukuda, Yuki
    Nakayama, Kayoko
    Okamura, Yuriko
    Tsuchiya, Hiroyuki
    Fukuzawa, Kenji
    Harashima, Hedeyoshi
    Kogure, Kentaro
    JOURNAL OF CONTROLLED RELEASE, 2012, 161 (03) : 843 - 851
  • [3] Nanoparticles Consisting of Tocopheryl Succinate Are a Novel Drug-Delivery System with Multifaceted Antitumor Activity
    Hama, Susumu
    Kogure, Kentaro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (02) : 196 - 200
  • [4] Targeted drug delivery nanosystems based on copolymer poly(lactide)-tocopheryl polyethylene glycol succinate for cancer treatment
    Phuong Thu Ha
    Hoai Nam Nguyen
    Hai Doan Do
    Quoc Thong Phan
    Minh Nguyet Tran Thi
    Xuan Phuc Nguyen
    My Nhung Hoang Thi
    Mai Huong Le
    Linh Toan Nguyen
    Thuc Quang Bui
    Van Hieu Phan
    ADVANCES IN NATURAL SCIENCES-NANOSCIENCE AND NANOTECHNOLOGY, 2016, 7 (01)
  • [5] Nanoparticles of poly(lactide) - Tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery
    Lee, Sie Huey
    Zhang, Zhiping
    Feng, Si-Shen
    BIOMATERIALS, 2007, 28 (11) : 2041 - 2050
  • [6] Application of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in transdermal and topical drug delivery systems (TDDS)
    Pham C.V.
    Cho C.-W.
    Journal of Pharmaceutical Investigation, 2017, 47 (2) : 111 - 121
  • [7] Improved biopharmaceutical properties of carvedilol employing α-tocopheryl polyethylene glycol 1000 succinate-based self-emulsifying drug delivery system
    Haider, Shimul
    Ogino, Mizuki
    Seto, Yoshiki
    Sato, Hideyuki
    Onoue, Satomi
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (11) : 1838 - 1844
  • [8] Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate
    Singh, Yuvraj
    Viswanadham, K. K. Durga Rao
    Pawar, Vivek K.
    Meher, Jayagopal
    Jajoriya, Arun Kumar
    Omer, Ankur
    Jaiswal, Swati
    Dewangan, Jayant
    Bora, H. K.
    Singh, Poonam
    Rath, Srikanta Kumar
    Lal, Jawahar
    Mishra, Durga Prasad
    Chourasia, Manish Kumar
    MOLECULAR PHARMACEUTICS, 2019, 16 (09) : 3744 - 3759
  • [9] Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate
    Bajaj, Amrita
    Rao, Monica R. P.
    Khole, Ishwar
    Munjapara, Ghansham
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (05) : 635 - 645
  • [10] Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ε-caprolactone nanoparticles for protein/peptide drug delivery
    Rayaprolu, Bindhu Madhavi
    Strom, James G.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (07) : 1046 - 1052